NSCLC, STAGE I

Clinical trials for NSCLC, STAGE I explained in plain language.

Never miss a new study

Get alerted when new NSCLC, STAGE I trials appear

Sign up with your email to follow new studies for NSCLC, STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to shield lungs during cancer radiation

Disease control Recruiting now

This study is testing whether a drug called BIO 300 can help protect the lungs of patients who have both early-stage lung cancer and a separate lung scarring disease (interstitial lung disease) when they receive radiation therapy. The main goal is to see if BIO 300 can prevent se…

Matched conditions: NSCLC, STAGE I

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

NSCLC, STAGE I

Get alerted when new NSCLC, STAGE I trials appear

New drug aims to shield lungs during cancer radiation